deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02831582

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation

Sponsor: Ohio State University Comprehensive Cancer Center

Conditions Arthralgia Breast Neoplasms
Interventions Omega-3 Fatty Acid Placebo
Updated 13 times since 2017 Last updated: Feb 24, 2023 Started: Oct 12, 2016 Primary completion: Dec 11, 2021 Completion: Dec 11, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02831582, this NA trial focuses on Arthralgia and Breast Neoplasms and remains completed. Sponsored by Ohio State University Comprehensive Cancer Center, it has been updated 13 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshot~Sep 2019 – ~Jul 2020 · 10 months · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Feb 2023 · 24 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  4. Feb 2023 — Mar 2023 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Feb 2021 — Feb 2023 [monthly]

    Recruiting NA

    Phase: PHASE2 → NA

▶ Show 8 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  3. Jul 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  4. Sep 2019 — Jul 2020 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended · Phase: NA → PHASE2

  5. Jun 2018 — Sep 2019 [monthly]

    Recruiting NA

  6. Sep 2017 — Jun 2018 [monthly]

    Recruiting NA

  7. Feb 2017 — Sep 2017 [monthly]

    Recruiting NA

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ohio State University Comprehensive Cancer Center
Data source: Ohio State University Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations